Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association

J Rangaswami, V Bhalla, JEA Blair, TI Chang, S Costa… - Circulation, 2019‏ - ahajournals.org
Cardiorenal syndrome encompasses a spectrum of disorders involving both the heart and
kidneys in which acute or chronic dysfunction in 1 organ may induce acute or chronic …

Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not …

SM Dunlay, MM Givertz, D Aguilar, LA Allen, M Chan… - Circulation, 2019‏ - ahajournals.org
Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of
morbidity and mortality in patients with established disease. Secular trends in the …

Evidence-based medical therapy in patients with heart failure with reduced ejection fraction and chronic kidney disease

IE Beldhuis, CSP Lam, JM Testani, AA Voors… - Circulation, 2022‏ - ahajournals.org
Chronic kidney disease (CKD) as identified by a reduced estimated glomerular filtration rate
(eGFR) is a common comorbidity in patients with heart failure with reduced ejection fraction …

Kidney function and outcomes in patients hospitalized with heart failure

RB Patel, GC Fonarow, SJ Greene, S Zhang… - Journal of the American …, 2021‏ - jacc.org
Background Few contemporary data exist evaluating care patterns and outcomes in heart
failure (HF) across the spectrum of kidney function. Objectives This study sought to …

Chronic kidney disease as a comorbidity in heart failure

M Szlagor, J Dybiec, E Młynarska, J Rysz… - International journal of …, 2023‏ - mdpi.com
Heart failure (HF) is one of the greatest problems in healthcare and it often coexists with
declining renal function. The pathophysiology between the heart and the kidneys is …

Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials

X **e, Y Liu, V Perkovic, X Li, T Ninomiya… - American Journal of …, 2016‏ - Elsevier
Background There is much uncertainty regarding the relative effects of angiotensin-
converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in …

Heart failure in patients with chronic kidney disease: a systematic integrative review

L Segall, I Nistor, A Covic - BioMed research international, 2014‏ - Wiley Online Library
Introduction. Heart failure (HF) is highly prevalent in patients with chronic kidney disease
(CKD) and end‐stage renal disease (ESRD) and is strongly associated with mortality in …

How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC

G Savarese, F Lindberg, A Cannata… - European journal of …, 2024‏ - Wiley Online Library
Guideline‐directed medical therapy (GDMT) in patients with heart failure and reduced
ejection fraction (HFrEF) reduces morbidity and mortality, but its implementation is often poor …

Management of heart failure patient with CKD

D Banerjee, G Rosano, CA Herzog - Clinical Journal of the …, 2021‏ - journals.lww.com
CKD is common in patients with heart failure, associated with high mortality and morbidity,
which is even higher in people undergoing long-term dialysis. Despite increasing use of …

[HTML][HTML] Heart failure in patients with diabetes and chronic kidney disease: challenges and opportunities

K Vijay, BL Neuen, EV Lerma - Cardiorenal medicine, 2022‏ - karger.com
Background: Heart failure (HF), diabetes mellitus (DM), and chronic kidney disease (CKD)
are commonly occurring and interlinked conditions. Approximately 25%–40% of patients …